Aspen Aerogels (NYSE:ASPN) Upgraded at Zacks Research

Zacks Research upgraded shares of Aspen Aerogels (NYSE:ASPN) from a strong sell rating to a hold rating in a research report report published on Thursday,Zacks.com reports.

Other analysts also recently issued reports about the company. Barclays cut their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Finally, Canaccord Genuity Group decreased their price objective on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $12.67.

Aspen Aerogels Stock Up 0.9%

Shares of NYSE ASPN opened at $3.48 on Thursday. The company has a market capitalization of $287.61 million, a P/E ratio of -0.94 and a beta of 2.94. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The company has a 50 day simple moving average of $3.20 and a 200-day simple moving average of $5.83. Aspen Aerogels has a 1 year low of $2.80 and a 1 year high of $12.90.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The business had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The company’s revenue was down 37.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.17) earnings per share. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities research analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current year.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the sale, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This represents a 10.32% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

A number of large investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC boosted its holdings in Aspen Aerogels by 1,094.8% in the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after purchasing an additional 4,390 shares during the period. SBI Securities Co. Ltd. increased its stake in shares of Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after buying an additional 2,551 shares during the period. Tower Research Capital LLC TRC raised its holdings in Aspen Aerogels by 184.6% in the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after acquiring an additional 4,693 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in Aspen Aerogels in the first quarter valued at approximately $43,000. Finally, Probity Advisors Inc. purchased a new position in Aspen Aerogels in the second quarter worth approximately $63,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.